Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
7.38
+0.19 (2.64%)
Aug 12, 2026, 9:57 AM EDT - Market open
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $161 million as of August 12, 2026. Its market cap has decreased by -33.44% in one year.
Market Cap
161.00M
Enterprise Value
87.81M
1-Year Change
-33.44%
Ranking
Category
Stock Price
$7.38
ChartMarket Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $161.00M, a decrease of -52.94%. That is a compound annual growth rate of -39.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 161.00M | -43.66% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 167.62M |
| Nkarta | 166.89M |
| OnKure Therapeutics | 165.63M |
| LENZ Therapeutics | 163.36M |
| Codexis | 159.19M |
| Kazia Therapeutics | 158.61M |
| Armata Pharmaceuticals | 156.02M |
| Jyong Biotech | 155.89M |